Premium
Is transureteroureterostomy performed during multi‐organ resection for non‐urothelial malignancy safe and effective?
Author(s) -
Pisters Phillip W.,
Pettaway Curtis A.,
Liu Ping,
Matin Surena F.,
Ward John F.,
Leibovici Dan
Publication year - 2012
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.23039
Subject(s) - medicine , hydronephrosis , renal function , malignancy , urology , creatinine , retrospective cohort study , kidney , surgery , resection , bladder cancer , urothelial cancer , kidney cancer , cancer , urinary system
Background Multi‐organ resection in patients with non‐urothelial cancer may include segmental ureteral resection. The resulting ureteral defect can be reconstructed with a transureteroureterostomy (TUU); however, whether TUU is safe and effective in this patient group remains unclear. Objectives In the current retrospective analysis, we evaluated renal function before and after complex multi‐organ resection that included TUU to determine whether TUU is safe and effective. Methods We retrospectively reviewed the charts of patients who underwent TUU between 1995 and 2011. Renal imaging studies performed before and after TUU were used to determine whether hydronephrosis was present in either kidney. Kidney function was assessed by measuring serum creatinine levels and calculating the estimated glomerular filtration rate (eGFR) before and after TUU. Results Twelve patients underwent TUU during multiorgan resection. Median follow‐up time was 15 months. Three patients with cancer recurrence involving the TUU developed progressive hydronephrosis. Serum creatinine levels did not increase more than 0.5 mg/dl in any patient. Kidney function as assessed by eGFR was maintained in all patients (until the time of recurrence in the three patients with recurrence affecting the TUU). Conclusions TUU during multi‐organ resection for non‐urothelial malignancy is safe and effective. Long‐term renal function is maintained in the majority of patients. J. Surg. Oncol. 2012; 106:62–65. © 2012 Wiley Periodicals, Inc.